WASHINGTON (Reuters) - The U.S. Securities and Exchange Commission said on Monday that it had settled charges with Becton Dickinson (NYSE:BDX) and Co. (BD) over allegations it misled investors about risks associated with its Alaris infusion pump.
The SEC said Becton Dickinson agreed to pay a $175 million civil penalty to settle the charges, which also allege that the company overstated its income by failing to disclose the costs of software repairs associated with the pump.BD did not admit to or deny the SEC's charges, but said in a statement that a settlement is the "right course of action to fully resolve this matter and move forward."
BD said the company would not need to issue financial restatements as a result of the settlement.
ProPicks AI evaluates BDX alongside thousands of other companies every month using 100+ financial metrics. Using powerful AI to generate exciting stock ideas, it looks beyond popularity to assess fundamentals, momentum, and valuation. The AI has no bias—it simply identifies which stocks offer the best risk-reward based on current data with notable past winners that include Super Micro Computer (+185%) and AppLovin (+157%). Want to know if BDX is currently featured in any ProPicks AI strategies, or if there are better opportunities in the same space?